DNA 마이크로어레이 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global DNA microarray market size is expected to reach USD 6.29 Billion in 2034 from USD 3.01 Billion in 2025, growing at a CAGR of 8.54 during 2026-2034.This market is growing steadily due to increasing applications in genomics research, disease diagnosis, drug discovery, and personalized medicine. DNA microarray technology enables the simultaneous analysis of thousands of genes, helping researchers understand gene expression patterns and genetic variations. Rising investments in biotechnology and life science research are creating strong demand for advanced genomic analysis tools across academic, clinical, and pharmaceutical settings.

The market is benefiting from advancements in molecular biology, genomics, and bioinformatics technologies. DNA microarrays play a critical role in cancer research, genetic disorder identification, and biomarker discovery. Growing interest in precision medicine and targeted therapeutics is encouraging broader adoption of genomic testing solutions. Expanding research funding and increasing collaboration between academic institutions and biotechnology companies are further driving market growth.

Future prospects remain favorable as genomic medicine continues to advance. The integration of artificial intelligence and data analytics with genomic research is expected to improve research efficiency and clinical outcomes. Expanding applications in drug development and disease monitoring will create additional growth opportunities. As healthcare increasingly moves toward personalized treatment approaches, the DNA microarray market is expected to witness sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• DNA Microarrays
• Oligonucleotide Microarrays
• Other Types (BAC & SNP arrays)

By Application

• Gene Expression Analysis
• Genotyping & SNP Analysis
• Epigenetics
• Pathogen Detection & Infectious Disease Panels

By Component

• Consumables (Slides, Reagents, Kits)
• Instruments (Scanners, Spotters, Washers)
• Services & Bioinformatics Software

By Technology

• In-situ Synthesized Oligonucleotide Arrays
• Spotted Microarrays (Contact / Non-contact)
• Photolithographic Arrays
• Inkjet Microarrays
• Other Technologies

By End User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Research & Academic Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific, Agilent Technologies, Illumina, F. Hoffmann-La Roche, Revvity, QIAGEN, Merck KGaA, Bio-Rad Laboratories, Sysmex, BIOMERIEUX, Macrogen, Greiner Bio-One, Toray Industries, Schott AG, CapitalBio Technology

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA MICROARRAY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. DNA Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Oligonucleotide Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Other Types (BAC & SNP arrays) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA MICROARRAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Gene Expression Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Genotyping & SNP Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Epigenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pathogen Detection & Infectious Disease Panels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA MICROARRAY MARKET: BY COMPONENT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Component
• 6.2. Consumables (Slides, Reagents, Kits) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Instruments (Scanners, Spotters, Washers) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Services & Bioinformatics Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA MICROARRAY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Technology
• 7.2. In-situ Synthesized Oligonucleotide Arrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Spotted Microarrays (Contact / Non-contact) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Photolithographic Arrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Inkjet Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA MICROARRAY MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Hospitals & Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DNA MICROARRAY MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Application
  • 9.2.3 By Component
  • 9.2.4 By Technology
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Application
  • 9.3.3 By Component
  • 9.3.4 By Technology
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Application
  • 9.4.3 By Component
  • 9.4.4 By Technology
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Application
  • 9.5.3 By Component
  • 9.5.4 By Technology
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Application
  • 9.6.3 By Component
  • 9.6.4 By Technology
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DNA MICROARRAY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher Scientific
  • 11.2.2 Agilent Technologies
  • 11.2.3 Illumina
  • 11.2.4 F. Hoffmann-La Roche
  • 11.2.5 Revvity
  • 11.2.6 QIAGEN
  • 11.2.7 Merck KGaA
  • 11.2.8 Bio-Rad Laboratories
  • 11.2.9 Sysmex
  • 11.2.10 bioMerieux S.A.
  • 11.2.11 Macrogen
  • 11.2.12 Greiner Bio-One
  • 11.2.13 Toray Industries
  • 11.2.14 Schott AG
  • 11.2.15 CapitalBio Technology